Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Piramal

    Tag: piramal

    You Searched For "Piramal"
    Sourav Ganguly becomes the brand Ambassador for Piramals antacid Polycrol

    Sourav Ganguly becomes the brand Ambassador for Piramal's antacid Polycrol

    Medical Dialogues Bureau27 Feb 2020 2:02 PM IST
    Available in a mint flavour, Polycrol is one of India's leading liquid antacid brands, and is amongst the top 3 in Eastern India, including West...
    Piramal Divests its Healthcare analytics Business for 950 Million USD

    Piramal Divests its Healthcare analytics Business for 950 Million USD

    Medical Dialogues Bureau18 Jan 2020 3:30 PM IST
    India: Piramal Enterprises Limited has announced that PEL DRG Dutch HoldCo BV, a 100% subsidiary of PEL and the holding company for Decision Resources...
    Piramal Enterprises plans to raise upto Rs 1000 crore via NCDs

    Piramal Enterprises plans to raise upto Rs 1000 crore via NCDs

    Medical Dialogues Bureau28 Oct 2019 9:45 AM IST
    The administrative committee of the board approved the issue of secured NCDs on private placement basis up to Rs 500 crore with an option to retain...
    Piramal Enterprises Q1 profit rises 21 percent to Rs 461 crore

    Piramal Enterprises Q1 profit rises 21 percent to Rs 461 crore

    Medical Dialogues Bureau31 July 2019 9:00 AM IST
    Piramal Enterprises said its total loan book grew 20 per cent year-on-year to Rs 56,605 crore. The housing finance loan book, which constitutes 11 per...
    Piramal cuts short-term borrowings, reduces dependence on CPs as NBFC crisis lingers

    Piramal cuts short-term borrowings, reduces dependence on CPs as NBFC crisis lingers

    Medical Dialogues Bureau12 July 2019 9:15 AM IST
    Piramal Enterprises chairman Ajay Piramal in his address to the shareholders in the FY19 annual report said the company continues to build resilience...
    Piramal Pharma invests over Rs 69 crore to expand its API capability

    Piramal Pharma invests over Rs 69 crore to expand its API capability

    Medical Dialogues Bureau21 Jun 2019 10:00 AM IST
    The new wing at the Riverview site is dedicated to the production of HPAPIs with low occupational exposure levels (OELs), Piramal Pharma Solutions...
    Panacea Biotec Bail out: Piramal, Bain offer Rs 992 crore deal

    Panacea Biotec Bail out: Piramal, Bain offer Rs 992 crore deal

    Garima9 April 2019 9:45 AM IST
    MUMBAI: India Resurgence Fund (IRF) led by Piramal Enterprises and Bain Capital Credit recently said it will invest Rs 992 crore in New Delhi-based...
    Supreme Court lifts ban on Saridon, major relief to Piramal

    Supreme Court lifts ban on Saridon, major relief to Piramal

    Meghna A Singhania21 Feb 2019 6:05 PM IST
    New Delhi: In a major relief to Piramal, the Supreme Court has exempted the popular painkiller drug Saridon from the list of Fixed Dose Combinations...
    Piramal Enterprises plans to raise up to Rs 1,000 crore via non-convertible debentures

    Piramal Enterprises plans to raise up to Rs 1,000 crore via non-convertible debentures

    Medical Dialogues Bureau22 Nov 2018 4:37 PM IST
    NEW DELHI: Piramal Enterprises on Wednesday said it plans to raise up to Rs 1,000 crore through issue of secured non-convertible debentures (NCDs) on...
    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Medical Dialogues Bureau18 Sept 2018 12:47 PM IST
    Supreme court lifted the ban on the sale of Piramal Healthcare's Saridon, GlaxoSmithKline's Piriton, Juggat Pharma's Dart and another drug, banned...
    Piramal acquires Digeplex from Shreya Lifesciences

    Piramal acquires Digeplex from Shreya Lifesciences

    Ruby Khatun Khatun1 Dec 2017 11:00 AM IST
    MUMBAI: Piramal Enterprises acquired the Digeplex and the associated brands from Shreya Lifesciences for an undisclosed sum to expand its consumer...
    Piramal group expands healthcare project ASARA

    Piramal group expands healthcare project ASARA

    Ruby Khatun Khatun10 Nov 2017 10:31 AM IST
    Vishakhapatnam: Piramal Swasthya, an initiative under the aegis of Piramal Foundation (the philanthropic arm of the Piramal Group), announced the...
    Next

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok